Metabolic syndrome was a risk factor for developing young-onset dementia, along with Alzheimer’s disease and vascular ...

Two-thirds of girls aged 13 to 17 years live in states with abortion bans, gestational limits or parental involvement laws, ...

An anthrax outbreak in the Democratic Republic of the Congo has left one person and dozens of animals dead, health officials ...

Positive changes in medicine can be obtained through advocacy and educating patients about the health care system, according ...

Early in 2024, the American Academy of Orthopaedic Surgeons board of directors approved a new strategic plan, which included ...

Edwards Lifesciences announced the FDA approved its transcatheter aortic valve replacement platform for treatment of severe ...

With mepolizumab vs. placebo, patients with COPD and type 2 inflammation experienced significantly fewer moderate/severe ...

Epigenetic changes — particularly altered DNA methylation — at birth may be associated with risk for metabolic dysfunction ...

Neoadjuvant immunotherapy alone resulted in significant treatment response among most patients with mismatch-repair-deficient ...

The American College of Allergy, Asthma & Immunology selected Luz S. Fonacier, MD, FACAAI, FAAAAI, as the 24th recipient of the Gold Headed Cane Award, presented during its annual meeting last year, ...

Cancer-related fatigue and depression led to a nearly twofold reduction in recreational activities among a national cohort of cancer survivors, according to study results.Of note, women cancer ...

The FDA granted fast track designation to urcosimod to treat neuropathic corneal pain, according to a press release from Okyo Pharma. Urcosimod, formerly called OK-101, is a “lipid conjugated chemerin ...